New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareTripeptide-29 vs Dermorphin

Tripeptide-29 vs Dermorphin

Side-by-side comparison of key properties, dosing, and research.

Skin & CosmeticAnti-Aging & Longevity
Tripeptide-29
Recovery & Repair
Dermorphin
Summary
Tripeptide-29 is a pro-collagen cosmetic peptide composed of proline, hydroxyproline, and glycine — the core repeating unit of collagen. Applied topically, it signals dermal fibroblasts that collagen degradation has occurred, triggering compensatory new collagen synthesis.
Dermorphin is a naturally occurring heptapeptide opioid isolated from the skin of South American phyllomedusine frogs. It is one of the most potent endogenous mu-opioid receptor agonists known, approximately 30-40 times more potent than morphine by weight. Explored for pain management and fatigue modulation.
Half-Life
Not applicable (topical)
Estimated 30-60 minutes (longer than endorphins due to D-Ala)
Admin Route
Topical
Subcutaneous (research), Intrathecal (research), Intranasal (research)
Research
Typical Dose
0.01-0.1% in formulation
Not established for human use; research doses vary widely
Frequency
Once or twice daily
Not established
Key Benefits
  • Stimulates fibroblast collagen synthesis via damage-signal mechanism
  • Reduces fine lines and improves skin smoothness
  • Supports dermal matrix integrity
  • Naturally bioidentical to collagen fragment sequences
  • Well-tolerated in all skin types
  • Synergistic with copper peptides and retinoids
  • Potent analgesia superior to morphine on a per-weight basis
  • May reduce perception of fatigue in high-intensity activity
  • Longer-lasting than endogenous opioids due to D-amino acid substitution
  • Research tool for mu-opioid receptor pharmacology
  • Potential therapeutic application in refractory pain
Side Effects
  • Excellent tolerability profile
  • No documented significant adverse effects at cosmetic concentrations
  • Rare sensitivity reactions in individuals with peptide allergies
  • High addiction and dependence potential (mu-opioid agonism)
  • Respiratory depression at high doses
  • Nausea, vomiting, constipation
  • Sedation and cognitive impairment
  • +2 more
Stacks With